180 related articles for article (PubMed ID: 27185390)
1. Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71.
Zhang L; Huang G; Cai Q; Zhao C; Tang L; Ren H; Li P; Li N; Huang J; Chen X; Guan Y; You H; Chen S; Li J; Lin T
J Mol Recognit; 2016 Nov; 29(11):520-527. PubMed ID: 27185390
[TBL] [Abstract][Full Text] [Related]
2. Fragment-wise design of inhibitors to 3C proteinase from enterovirus 71.
Wu C; Zhang L; Li P; Cai Q; Peng X; Yin K; Chen X; Ren H; Zhong S; Weng Y; Guan Y; Chen S; Wu J; Li J; Lin T
Biochim Biophys Acta; 2016 Jun; 1860(6):1299-307. PubMed ID: 26987809
[TBL] [Abstract][Full Text] [Related]
3. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
[TBL] [Abstract][Full Text] [Related]
4. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.
Ma GH; Ye Y; Zhang D; Xu X; Si P; Peng JL; Xiao YL; Cao RY; Yin YL; Chen J; Zhao LX; Zhou Y; Zhong W; Liu H; Luo XM; Chen LL; Shen X
Eur J Med Chem; 2016 Nov; 124():981-991. PubMed ID: 27776325
[TBL] [Abstract][Full Text] [Related]
5. Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease.
Zhai Y; Zhao X; Cui Z; Wang M; Wang Y; Li L; Sun Q; Yang X; Zeng D; Liu Y; Sun Y; Lou Z; Shang L; Yin Z
J Med Chem; 2015 Dec; 58(23):9414-20. PubMed ID: 26571192
[TBL] [Abstract][Full Text] [Related]
6. Luteoloside Acts as 3C Protease Inhibitor of Enterovirus 71 In Vitro.
Cao Z; Ding Y; Ke Z; Cao L; Li N; Ding G; Wang Z; Xiao W
PLoS One; 2016; 11(2):e0148693. PubMed ID: 26870944
[TBL] [Abstract][Full Text] [Related]
7. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study.
Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS
J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents.
Kuo CJ; Shie JJ; Fang JM; Yen GR; Hsu JT; Liu HG; Tseng SN; Chang SC; Lee CY; Shih SR; Liang PH
Bioorg Med Chem; 2008 Aug; 16(15):7388-98. PubMed ID: 18583140
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay.
Shang L; Zhang S; Yang X; Sun J; Li L; Cui Z; He Q; Guo Y; Sun Y; Yin Z
Antimicrob Agents Chemother; 2015 Apr; 59(4):1827-36. PubMed ID: 25421478
[TBL] [Abstract][Full Text] [Related]
11. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design.
Lu G; Qi J; Chen Z; Xu X; Gao F; Lin D; Qian W; Liu H; Jiang H; Yan J; Gao GF
J Virol; 2011 Oct; 85(19):10319-31. PubMed ID: 21795339
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of human enterovirus 71 3C protease.
Cui S; Wang J; Fan T; Qin B; Guo L; Lei X; Wang J; Wang M; Jin Q
J Mol Biol; 2011 May; 408(3):449-61. PubMed ID: 21396941
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship of α-keto amides as enterovirus 71 3C protease inhibitors.
Zeng D; Ma Y; Zhang R; Nie Q; Cui Z; Wang Y; Shang L; Yin Z
Bioorg Med Chem Lett; 2016 Apr; 26(7):1762-6. PubMed ID: 26916437
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.
Namoto K; Sirockin F; Sellner H; Wiesmann C; Villard F; Moreau RJ; Valeur E; Paulding SC; Schleeger S; Schipp K; Loup J; Andrews L; Swale R; Robinson M; Farady CJ
Bioorg Med Chem Lett; 2018 Mar; 28(5):906-909. PubMed ID: 29433930
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease.
Tan YW; Ang MJ; Lau QY; Poulsen A; Ng FM; Then SW; Peng J; Hill J; Hong WJ; Chia CS; Chu JJ
Sci Rep; 2016 Sep; 6():33663. PubMed ID: 27645381
[TBL] [Abstract][Full Text] [Related]
16. 4-Iminooxazolidin-2-one as a Bioisostere of the Cyanohydrin Moiety: Inhibitors of Enterovirus 71 3C Protease.
Ma Y; Shang C; Yang P; Li L; Zhai Y; Yin Z; Wang B; Shang L
J Med Chem; 2018 Nov; 61(22):10333-10339. PubMed ID: 30365311
[TBL] [Abstract][Full Text] [Related]
17. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
Wanga QM; Chen SH
Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
[TBL] [Abstract][Full Text] [Related]
18. A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity.
Li B; Yue Y; Zhang Y; Yuan Z; Li P; Song N; Lin W; Liu Y; Gu L; Meng H
Front Cell Infect Microbiol; 2017; 7():26. PubMed ID: 28217559
[TBL] [Abstract][Full Text] [Related]
19. Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease.
Kawatkar SP; Gagnon M; Hoesch V; Tiong-Yip C; Johnson K; Ek M; Nilsson E; Lister T; Olsson L; Patel J; Yu Q
Bioorg Med Chem Lett; 2016 Jul; 26(14):3248-3252. PubMed ID: 27265257
[TBL] [Abstract][Full Text] [Related]
20. Structure of the Enterovirus 71 3C Protease in Complex with NK-1.8k and Indications for the Development of Antienterovirus Protease Inhibitor.
Wang Y; Cao L; Zhai Y; Yin Z; Sun Y; Shang L
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
